title: Optimization of cryoprotectant treatment for the vitrification of immature cumulus-enclosed porcine oocytes: comparison of sugars, combinations of permeating cryoprotectants and equilibration regimens.
abstract: Our aim was to optimize the cryoprotectant treatment for the preservation of immature porcine cumulus-oocyte complexes (COCs) by solid surface vitrification. In each experiment, the vitrification solution consisted of 50 mg/ml polyvinyl pyrrolidone, 0.3 M of the actual sugar and in total 35% (v/v) of the actual permeating cryoprotectant (pCPA) combination. After warming, the COCs were subjected to in vitro maturation, fertilization and embryo culture. In Experiment 1, trehalose and sucrose were equally effective during vitrification and warming in terms of facilitating oocyte survival and subsequent embryo development. In Experiment 2, when equilibration was performed at 38.5 C in a total of 4% (v/v) pCPA for 15 min, the combination of ethylene glycol and propylene glycol (EG + PG = 1:1) was superior to EG and dimethyl sulfoxide (EG + DMSO = 1:1) in terms of oocyte survival after vitrification and the quality of resultant blastocysts. In Experiment 3, equilibration in 4% (v/v) pCPA for 15 min before vitrification was superior to that in 15% (v/v) CPA for 5 min for achievement of high survival rates irrespective of the pCPA combination used. In Experiment 4, when equilibration was performed in 4% EG + PG for 5 min, 15 min or 25 min, there was no difference in oocyte survival and subsequent embryo development after vitrification and warming; however, the developmental competence of cleaved embryos was tendentiously reduced when equilibration was performed for 25 min. In conclusion, trehalose and sucrose were equally effective in facilitating vitrification, and the optimum pCPA treatment was 5-15 min equilibration in 4% (v/v) of EG + PG followed by vitrification in 35% (v/v) EG + PG.
authors.affiliation: NARO Institute of Livestock and Grassland Science, Ibaraki 305-0901, Japan.
authors.forename: Tamás
authors.initials: T
authors.lastname: Somfai
authors.forename: Nguyen Thi
authors.initials: NT
authors.lastname: Men
authors.forename: Junko
authors.initials: J
authors.lastname: Noguchi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kaneko
authors.forename: Naomi
authors.initials: N
authors.lastname: Kashiwazaki
authors.forename: Kazuhiro
authors.initials: K
authors.lastname: Kikuchi
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D003451:Cryoprotective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D004121:Dimethyl Sulfoxide / Q000494:pharmacology; D047108:Embryonic Development / Q000187:drug effects; D019855:Ethylene Glycol / Q000494:pharmacology; D005260:Female; D009865:Oocytes / Q000187:drug effects / Q000502:physiology*; D011205:Povidone / Q000493:pharmacokinetics / Q000506:poisoning; D019946:Propylene Glycol / Q000494:pharmacology; D013395:Sucrose / Q000494:pharmacology; D013552:Swine; D014199:Trehalose / Q000494:pharmacology; D058989:Vitrification / Q000187:drug effects*
chemical_list: D003451:Cryoprotective Agents; D013395:Sucrose; D019946:Propylene Glycol; D014199:Trehalose; D019855:Ethylene Glycol; D011205:Povidone; D004121:Dimethyl Sulfoxide